MCC market seen reaching $2.3 billion by 2033

Persistence Market Research says the global microcrystalline cellulose market will grow from $1.4 billion in 2026 to $2.3 billion by 2033, driven by pharmaceutical tablets, processed foods and multifunctional excipients. North America is projected to lead in 2026, while Asia-Pacific is expected to grow the fastest through 2033.

Why it matters: - Microcrystalline cellulose is a core excipient in tablets and a functional ingredient in food and personal care products, so growth in the market signals broader demand across pharma manufacturing and processed foods. - The market’s projected 7.3% CAGR through 2033 points to steady expansion in ingredients tied to product quality, stability and production efficiency.

What happened: - Persistence Market Research valued the global microcrystalline cellulose market at $1.4 billion in 2026 and projected it will reach $2.3 billion by 2033. - The forecast covers 2026 to 2033 and implies a 7.3% compound annual growth rate. - North America is expected to hold about 34% of the market in 2026. - Asia-Pacific is forecast to be the fastest-growing region through 2033.

The details: - Pharmaceutical tablet production remains the biggest demand driver because MCC supports binding, disintegration and compression in oral solid dosage forms. - Generic drug manufacturing and higher healthcare spending are adding to demand in developed and emerging markets. - Processed food demand is rising as urbanization and convenience-food consumption increase. - MCC is used in food products as a stabilizer, anti-caking agent, fat replacer and texturizer. - Personal care manufacturers use MCC in creams, lotions, powders and other cosmetic formulations for texture and stability. - The study points to rising use of multifunctional excipients that can simplify production while improving formulation performance. - Ongoing cellulose-processing advances are enabling customized MCC grades with better particle size distribution, compressibility and functional performance. - Sustainability trends are also supporting adoption because MCC is derived from natural cellulose sources.

Between the lines: - The strongest growth appears tied to volume industries, not niche uses, which suggests MCC demand is becoming more embedded in mainstream manufacturing. - Asia-Pacific’s growth outlook reflects a broader shift in pharmaceutical production and food processing capacity toward emerging markets. - The report’s focus on customized grades and strategic capacity expansion suggests suppliers are competing on performance as much as on price.

What's next: - Emerging economies in Asia-Pacific, Latin America and the Middle East are expected to keep building healthcare infrastructure and pharmaceutical manufacturing capacity. - The report expects more research and development spending on advanced MCC grades for specialized drug formulations and new food applications. - Market participants are likely to continue pursuing partnerships, capacity expansion and product innovation to defend share. - More information is available in the sample report and the customized market view.

The bottom line: - MCC is moving from a basic excipient to a higher-value functional ingredient, with pharma, food and personal care demand all supporting long-term growth.